Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants.
Frontiers In Oncology
Hallermayr, Ariane A; Neuhann, Teresa M TM; Steinke-Lange, Verena V; Scharf, Florentine F; Laner, Andreas A; Ewald, Roland R; Liesfeld, Ben B; Holinski-Feder, Elke E; Pickl, Julia M A JMA
Publication Date: 2022
Variant appearance in text: ERBB2: A775_G776insYVMA
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial.
Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.
Plos One
Chow, Yock Ping YP; Zainul Abidin, Norziha N; Kow, Ken Siong KS; Tho, Lye Mun LM; Wong, Chieh Lee CL
Publication Date: 2022
Variant appearance in text: ERBB2: A775_G776insYVMA
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.
Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.
International Journal Of Molecular Medicine
Chevrier, Sandy S; Brasselet, Astrid A; Carnet, Marion M; Chevriaux, Angélique A; Gibeaud, Anne A; Jourdain, Marine M; Mananet, Hugo H; Truntzer, Caroline C; Beltjens, Françoise F; Charon-Barra, Céline C; Arnould, Laurent L; Albuisson, Juliette J; Comte, Anthony A; Derangère, Valentin V; Goussot, Vincent V; Boidot, Romain R
Publication Date: 2022-05
Variant appearance in text: ERBB2: Ala775_Gly776insTyrValMetAla
Consensus for HER2 alterations testing in non-small-cell lung cancer.
Esmo Open
Ren, S S; Wang, J J; Ying, J J; Mitsudomi, T T; Lee, D H DH; Wang, Z Z; Chu, Q Q; Mack, P C PC; Cheng, Y Y; Duan, J J; Fan, Y Y; Han, B B; Hui, Z Z; Liu, A A; Liu, J J; Lu, Y Y; Ma, Z Z; Shi, M M; Shu, Y Y; Song, Q Q; Song, X X; Song, Y Y; Wang, C C; Wang, X X; Wang, Z Z; Xu, Y Y; Yao, Y Y; Zhang, L L; Zhao, M M; Zhu, B B; Zhang, J J; Zhou, C C; Hirsch, F R FR
Publication Date: 2022-02
Variant appearance in text: HER2: A775_G776insYVMA
Targeted Sequencing Revealed Distinct Mutational Profiles of Ocular and Extraocular Sebaceous Carcinomas.
Cancers
Na, Hee Young HY; Park, Jeong Hwan JH; Shin, Sun Ah SA; Lee, Sejoon S; Lee, Heonyi H; Chae, Heejoon H; Choung, HoKyung H; Kim, Namju N; Chung, Jin-Haeng JH; Kim, Ji Eun JE
Publication Date: 2021-09-26
Variant appearance in text: ERBB2: A775_G776insYVMA
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.
Radiation Oncology (London, England)
Schneider, Raik R; Gademann, Günther G; Ochel, Hans-Joachim HJ; Neumann, Karsten K; Jandrig, Burkhard B; Hass, Peter P; Walke, Mathias M; Schostak, Martin M; Brunner, Thomas T; Christoph, Frank F
Publication Date: 2021-07-28
Variant appearance in text: ERBB2: E770_A771insAYVM
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
International Journal Of Molecular Sciences
Rebuzzi, Sara Elena SE; Zullo, Lodovica L; Rossi, Giovanni G; Grassi, Massimiliano M; Murianni, Veronica V; Tagliamento, Marco M; Prelaj, Arsela A; Coco, Simona S; Longo, Luca L; Dal Bello, Maria Giovanna MG; Alama, Angela A; Dellepiane, Chiara C; Bennicelli, Elisa E; Malapelle, Umberto U; Genova, Carlo C
Publication Date: 2021-03-05
Variant appearance in text: HER2: A775_G776insYVMA
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
International Journal Of Clinical Oncology
Chang, Gee-Chen GC; Lam, David Chi-Leung DC; Tsai, Chun-Ming CM; Chen, Yuh-Min YM; Shih, Jin-Yuan JY; Aggarwal, Shyam S; Wang, Shuhang S; Kim, Sang-We SW; Kim, Young-Chul YC; Wahid, Ibrahim I; Li, Rubi R; Lim, Darren Wan-Teck DW; Sriuranpong, Virote V; Chan, Raymond Tsz-Tong RT; Lorence, Robert M RM; Carriere, Philippe P; Raabe, Christina C; Cseh, Agnieszka A; Park, Keunchil K
Publication Date: 2021-05
Variant appearance in text: HER2: A775_G776insYVMA
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Estrada-Bernal, Adriana A; Le, Anh T AT; Doak, Andrea E AE; Tirunagaru, Vijaya G VG; Silva, Shevan S; Bull, Matthew R MR; Smaill, Jeff B JB; Patterson, Adam V AV; Kim, Chul C; Liu, Stephen V SV; Doebele, Robert C RC
Publication Date: 2021-03-01
Variant appearance in text: HER2: A775_G776insYVMA
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.
Cells
Belloum, Yassine Y; Janning, Melanie M; Mohme, Malte M; Simon, Ronald R; Kropidlowski, Jolanthe J; Sartori, Alexander A; Irwin, Darryl D; Westphal, Manfred M; Lamszus, Katrin K; Loges, Sonja S; Riethdorf, Sabine S; Pantel, Klaus K; Wikman, Harriet H
Publication Date: 2020-10-22
Variant appearance in text: ERBB2: A775_G776insYVMA
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study.
Cancers
Lamy, Pierre-Jean PJ; van der Leest, Paul P; Lozano, Nicolas N; Becht, Catherine C; Duboeuf, Frédérique F; Groen, Harry J M HJM; Hilgers, Werner W; Pourel, Nicolas N; Rifaela, Naomi N; Schuuring, Ed E; Alix-Panabières, Catherine C
Publication Date: 2020-10-16
Variant appearance in text: ERBB2: A775_G776insYVMA
Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.
International Journal Of Clinical And Experimental Pathology
Chen, Lingfeng L; Chen, Minyan M; Lin, Jie J; Chen, Xiaoyan X; Yu, Xunbin X; Chen, Zhizhong Z; Jin, Long L
Publication Date: 2020
Variant appearance in text: ERBB2: A775_G776insYVMA
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.
Nature Genetics
Wagner, Alex H AH; Walsh, Brian B; Mayfield, Georgia G; Tamborero, David D; Sonkin, Dmitriy D; Krysiak, Kilannin K; Deu-Pons, Jordi J; Duren, Ryan P RP; Gao, Jianjiong J; McMurry, Julie J; Patterson, Sara S; Del Vecchio Fitz, Catherine C; Pitel, Beth A BA; Sezerman, Ozman U OU; Ellrott, Kyle K; Warner, Jeremy L JL; Rieke, Damian T DT; Aittokallio, Tero T; Cerami, Ethan E; Ritter, Deborah I DI; Schriml, Lynn M LM; Freimuth, Robert R RR; Haendel, Melissa M; Raca, Gordana G; Madhavan, Subha S; Baudis, Michael M; Beckmann, Jacques S JS; Dienstmann, Rodrigo R; Chakravarty, Debyani D; Li, Xuan Shirley XS; Mockus, Susan S; Elemento, Olivier O; Schultz, Nikolaus N; Lopez-Bigas, Nuria N; Lawler, Mark M; Goecks, Jeremy J; Griffith, Malachi M; Griffith, Obi L OL; Margolin, Adam A AA; ,
Publication Date: 2020-04
Variant appearance in text: ERBB2: A775_G776insYVMA
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
Scientific Reports
McCabe, Mark J MJ; Gauthier, Marie-Emilie A MA; Chan, Chia-Ling CL; Thompson, Tanya J TJ; De Sousa, Sunita M C SMC; Puttick, Clare C; Grady, John P JP; Gayevskiy, Velimir V; Tao, Jiang J; Ying, Kevin K; Cipponi, Arcadi A; Deng, Niantao N; Swarbrick, Alex A; Thomas, Melissa L ML; Lord, Reginald V RV; Johns, Amber L AL; Kohonen-Corish, Maija M; O'Toole, Sandra A SA; Clark, Jonathan J; Mueller, Simon A SA; Gupta, Ruta R; McCormack, Ann I AI; Dinger, Marcel E ME; Cowley, Mark J MJ; ,
Publication Date: 2019-11-19
Variant appearance in text: ERBB2: A775_G776insYVMA
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Clinical & Translational Oncology : Official Publication Of The Federation Of Spanish Oncology Societies And Of The National Cancer Institute Of Mexico
Garrido, P P; Conde, E E; de Castro, J J; Gómez-Román, J J JJ; Felip, E E; Pijuan, L L; Isla, D D; Sanz, J J; Paz-Ares, L L; López-Ríos, F F
Publication Date: 2020-07
Variant appearance in text: HER2: A775_G776insYVMA
Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.
The Journal Of Molecular Diagnostics : Jmd
He, Hua-Jun HJ; Stein, Erica V EV; Konigshofer, Yves Y; Forbes, Thomas T; Tomson, Farol L FL; Garlick, Russell R; Yamada, Emiko E; Godfrey, Tony T; Abe, Toshiya T; Tamura, Koji K; Borges, Michael M; Goggins, Michael M; Elmore, Sandra S; Gulley, Margaret L ML; Larson, Jessica L JL; Ringel, Lando L; Haynes, Brian C BC; Karlovich, Chris C; Williams, P Mickey PM; Garnett, Aaron A; Ståhlberg, Anders A; Filges, Stefan S; Sorbara, Lynn L; Young, Mathew R MR; Srivastava, Sudhir S; Cole, Kenneth D KD
Publication Date: 2019-07
Variant appearance in text: ERBB2: A775_G776insYVMA
Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
Diagnostic Pathology
Grosse, Alexandra A; Grosse, Claudia C; Rechsteiner, Markus M; Soltermann, Alex A
Publication Date: 2019-02-11
Variant appearance in text: ERBB2: A775_G776insYVMA
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.
European Journal Of Cancer (Oxford, England : 1990)
Lai, W Victoria WV; Lebas, Louisiane L; Barnes, Tristan A TA; Milia, Julie J; Ni, Ai A; Gautschi, Oliver O; Peters, Solange S; Ferrara, Roberto R; Plodkowski, Andrew J AJ; Kavanagh, John J; Sabari, Joshua K JK; Clarke, Stephen J SJ; Pavlakis, Nick N; Drilon, Alexander A; Rudin, Charles M CM; Arcila, Maria E ME; Leighl, Natasha B NB; Shepherd, Frances A FA; Kris, Mark G MG; Mazières, Julien J; Li, Bob T BT
Publication Date: 2019-03
Variant appearance in text: HER2: A775_G776insYVMA
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.
Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Wang, Y Y; Jiang, T T; Qin, Z Z; Jiang, J J; Wang, Q Q; Yang, S S; Rivard, C C; Gao, G G; Ng, T L TL; Tu, M M MM; Yu, H H; Ji, H H; Zhou, C C; Ren, S S; Zhang, J J; Bunn, P P; Doebele, R C RC; Camidge, D R DR; Hirsch, F R FR
Publication Date: 2019-03-01
Variant appearance in text: HER2: A775_G776insYVMA